← Back to Search

Transcranial Magnetic Stimulation

Healthy Adult Speakers for Speech

N/A
Waitlist Available
Led By Carrie Niziolek, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 hour
Awards & highlights

Study Summary

This trial aims to understand how the brain processes & controls speech in healthy people. 15 participants will do 4 visits of 2-4 hrs each to help people with communication disorders.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Somatosensory acuity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy Adult SpeakersExperimental Treatment2 Interventions
healthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
somatosensory acuity measurement
2022
N/A
~20
TMS
2021
Completed Phase 2
~2170

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
328 Previous Clinical Trials
178,290 Total Patients Enrolled
11 Trials studying Speech
1,376 Patients Enrolled for Speech
University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,167,372 Total Patients Enrolled
3 Trials studying Speech
149 Patients Enrolled for Speech
Carrie Niziolek, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
3 Previous Clinical Trials
149 Total Patients Enrolled
3 Trials studying Speech
149 Patients Enrolled for Speech

Media Library

TMS (Transcranial Magnetic Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05723575 — N/A
Speech Research Study Groups: Healthy Adult Speakers
Speech Clinical Trial 2023: TMS Highlights & Side Effects. Trial Name: NCT05723575 — N/A
TMS (Transcranial Magnetic Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05723575 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor accommodate participants aged 55 and above?

"To be eligible for this study, applicants should fall within the 18 to 70-year-old age range. For those under 18 and over 65 years old, separate trials have been established with a total of 5 in all."

Answered by AI

Is this research endeavor accepting participants currently?

"According to the most recent update on clinicaltrials.gov, this medical trial is still in search of suitable applicants. It was first announced on November 18th 2022 and has been ammended as recently as February 1st 2023."

Answered by AI

How many participants are actively engaged in this clinical endeavor?

"Affirmative. The relevant data on clinicaltrials.gov suggests that this research is presently recruiting participants, with 15 patients needed from a single site since it was first posted on November 18th 2022 and most recently updated February 1st 2023."

Answered by AI

What qualifications must I meet to participate in this research?

"Fifteen adults, ranging in age from 18 to 70 years old and who are English-speaking with normal hearing and speech abilities, as well as no history of stroke or neurological issues may be eligible for this clinical trial regarding the development of speech."

Answered by AI
~6 spots leftby Apr 2025